Roche Holding AG Bearer Shares RHHBF
News
Roche Confirms Narrowed Pharma Focus, Fast Tracks Obesity-Drug Candidate
Regor to Sell Breast Cancer CDK Inhibitors to Roche Unit for Upfront $850 Million
Roche's Cancer Drug Candidate Shows Positive Results in Late Stage Trial
Roche Says Xofluza Achieved Positive Results in Phase 3 Influenza Trial
Roche Gets FDA Approval for Multiple-Sclerosis Treatment
Genentech Receives FDA Approval for Cancer Treatment
Genentech receives FDA approval for cancer treatment
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects — Update
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects
Zenas BioPharma, Bicara Therapeutics sets IPO price ranges as summer lull ends
Roche Gets EU Approval for Blood Disorder Injection PiaSky
Roche Weighs Divestment of Cancer Data Startup, FT Reports
Poseida Rises After Reporting Smaller-Than-Seen Loss, Partnership Progress
Roche to Speed Up Obesity Market Entry to Catch Up With Rivals, FT Reports
Roche Raises Earnings Guidance After Results Beat Market Expectations — Update
Roche Raises Guidance After Sales, Earnings Beat Market Expectations
Eli Lilly's stock plunges as investors eye obesity-drug competition
Roche obesity-pill trial results weigh on shares of Eli Lilly, Novo Nordisk
Roche Obesity Pill Achieves Positive Results in Early-Stage Trial — 3rd Update